Background One possible reason for increased mortality due to SARS-CoV-2 in patients
with diabetes is from the complication of diabetic ketoacidosis (DKA). Objectives To re …

Background and aim To conduct a systematic literature review and analyze the
demographic/biochemical parameters and clinical outcomes of COVID-19 patients with …

Background and objectives: To describe the clinical characteristics and outcomes of
hospitalized coronavirus disease 2019 (COVID-19) patients with diabetic ketoacidosis …

Background: Various reports described new-onset diabetes during or after severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in patients with no previous …

Background Diabetic ketoacidosis (DKA) is a potentially life-threatening complication of type
1 diabetes mellitus (T1DM) that has increased during the COVID-19 pandemic. This study …

In December 2019, a pandemic emerged due to a new coronavirus that imposed various
uncertainties and discoveries. It has been reported that diabetes is a risk factor for worst …

Aim-Patients with diabetes have increased morbidity and mortality from COVID-19. Case
reports describe patients with simultaneous COVID-19 and diabetic acidosis (DKA) …

Although recent data have shown a declining trend in mortality in diabetic ketoacidosis
(DKA), the outcomes are likely to be different during the coronavirus (COVID-19) pandemic …

Aims This study characterized incidence, patient profiles, risk factors and outcomes of in‐
hospital diabetic ketoacidosis (DKA) in patients with COVID‐19 compared with influenza …

Objective COVID-19 in people with diabetes is associated with a disproportionately worse
prognosis. DKA is an acute complication of diabetes with a mortality rate of approximately …